Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Greene

Showing results (1011-1020 of 1,076) with videos related to

Pageof 108
Sort By:
Biorxiv : the Preprint Server for Biology|August 8, 2025
Precision functional mapping reveals less inter-individual variability in the child vs. adult human brainDamion V Demeter, Matthew Feigelis, Carolina Badke D'Andrea, et al.
Circulation. Heart Failure|October 9, 2024
Home-Time, Mortality, and Readmissions Among Patients Hospitalized With Heart Failure: A Baseline Prior to IMPLEMENT-HFAmber B Tang, Nicole Solomon, Karen Chiswell, et al.
American Heart Journal Plus : Cardiology Research and Practice|December 11, 2025
A Pragmatic Trial Evaluating the Impact of the Anumana Clinical Decision Support Tool for Guideline-Directed Management of Heart Failure (ACT-HF): Clinical trial design and methodsFrancisco Lopez-Jimenez, Heather M Alger, Sarah P Hackett, et al.
Journal of the American Heart Association|August 5, 2021
Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection FractionStephen J Greene, Sujung Choi, Steven J Lippmann, et al.
The Journal of Urology|March 29, 2017
Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active SurveillanceYaw A Nyame, Nima Almassi, Samuel C Haywood, et al.
JAMA Cardiology|November 13, 2020
Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice: The Get With the Guidelines-Heart Failure (GWTG-HF) RegistryMuthiah Vaduganathan, Stephen J Greene, Shuaiqi Zhang, et al.
Injury Epidemiology|June 28, 2019
Protocol for serious fall injury adjudication in the Strategies to Reduce Injuries and Develop Confidence in Elders (STRIDE) studyDavid A Ganz, Albert L Siu, Jay Magaziner, et al.
Biochimica Et Biophysica Acta|May 22, 2010
Interaction of 10-(octyloxy) decyl-2-(trimethylammonium) ethyl phosphate with mimetic membranes and cytotoxic effect on leukemic cellsG A dos Santos, C H Thomé, G A Ferreira, et al.
American Heart Journal|July 29, 2014
Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registriesStephen J Greene, Ami N Shah, Javed Butler, et al.
Journal of the American College of Cardiology|June 21, 2023
Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient PopulationsMuhammad Shariq Usman, Tariq Jamal Siddiqi, Stefan D Anker, et al.
Pageof 108

Showing results (1011-1020 of 1,076) with videos related to

Sort By:
Pageof 108
Biorxiv : the Preprint Server for Biology|August 8, 2025
Precision functional mapping reveals less inter-individual variability in the child vs. adult human brainDamion V Demeter, Matthew Feigelis, Carolina Badke D'Andrea, et al.
Circulation. Heart Failure|October 9, 2024
Home-Time, Mortality, and Readmissions Among Patients Hospitalized With Heart Failure: A Baseline Prior to IMPLEMENT-HFAmber B Tang, Nicole Solomon, Karen Chiswell, et al.
American Heart Journal Plus : Cardiology Research and Practice|December 11, 2025
A Pragmatic Trial Evaluating the Impact of the Anumana Clinical Decision Support Tool for Guideline-Directed Management of Heart Failure (ACT-HF): Clinical trial design and methodsFrancisco Lopez-Jimenez, Heather M Alger, Sarah P Hackett, et al.
Journal of the American Heart Association|August 5, 2021
Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection FractionStephen J Greene, Sujung Choi, Steven J Lippmann, et al.
The Journal of Urology|March 29, 2017
Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active SurveillanceYaw A Nyame, Nima Almassi, Samuel C Haywood, et al.
JAMA Cardiology|November 13, 2020
Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice: The Get With the Guidelines-Heart Failure (GWTG-HF) RegistryMuthiah Vaduganathan, Stephen J Greene, Shuaiqi Zhang, et al.
Injury Epidemiology|June 28, 2019
Protocol for serious fall injury adjudication in the Strategies to Reduce Injuries and Develop Confidence in Elders (STRIDE) studyDavid A Ganz, Albert L Siu, Jay Magaziner, et al.
Biochimica Et Biophysica Acta|May 22, 2010
Interaction of 10-(octyloxy) decyl-2-(trimethylammonium) ethyl phosphate with mimetic membranes and cytotoxic effect on leukemic cellsG A dos Santos, C H Thomé, G A Ferreira, et al.
American Heart Journal|July 29, 2014
Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registriesStephen J Greene, Ami N Shah, Javed Butler, et al.
Journal of the American College of Cardiology|June 21, 2023
Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient PopulationsMuhammad Shariq Usman, Tariq Jamal Siddiqi, Stefan D Anker, et al.
Pageof 108